Dementia Drugs Market Size, Share & Industry Analysis, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Amyloid Beta-directed Antibodies), By Indication (Alzheimer's Disease and Parkinson's Disease Dementia), By Type (Branded and Generics), By Route of Administration (Oral, Parenteral, and Others), By Treatment Type (Symptomatic Cognitive Therapies, Disease-modifying Therapies, and Behavioral & Neuropsychiatric Symptom Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: August 13, 2026 | Format: PDF | Report ID: FBI118891

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 12.01% from 2026-2034
Unit	Value (USD Billion)
Segmentation	By Drug Class, Indication, Type, Route of Administration, Treatment Type, Distribution Channel, and Region
By Drug Class	Cholinesterase Inhibitors NMDA Receptor Antagonists Amyloid Beta-directed Antibodies Others
By Indication	Alzheimer’s Disease Parkinson’s Disease Dementia Others
By Type	Branded Generics
By Route of Administration	Oral Parenteral Others
By Treatment Type	Symptomatic Cognitive Therapies Disease-modifying Therapies Behavioral and Neuropsychiatric Symptom Therapies Others
By Distribution Channel	Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies Others
By Region	North America (By Drug Class, Indication, Type, Route of Administration, Treatment Type, Distribution Channel, and Country) U.S. Canada Europe (By Drug Class, Indication, Type, Route of Administration, Treatment Type, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Drug Class, Indication, Type, Route of Administration, Treatment Type, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Drug Class, Indication, Type, Route of Administration, Treatment Type, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Drug Class, Indication, Type, Route of Administration, Treatment Type, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of Middle East & Africa